Skip to main content
Pay Bill Portals

How MRD Testing Supports Colorectal Cancer Patients: Jason’s Story and the Importance of Regular Monitoring

Published Date

The Role of MRD Testing in Colorectal Cancer Care

For many colorectal cancer patients, the journey doesn’t end after surgery or initial treatment. The risk of recurrence remains, and staying ahead of the disease requires careful monitoring. Minimal Residual Disease (MRD) testing, like Signatera™, is a revolutionary tool that helps patients and their doctors track colorectal cancer at the molecular level, providing peace of mind and timely intervention when needed.

One patient who has experienced the benefits of MRD testing firsthand is Jason Randall, a Stage IV colorectal cancer survivor who has used Signatera™ to guide his treatment decisions and stay proactive in managing his health.

Jason’s Story: Taking Control with MRD Testing

Jason Randall’s journey with Stage IV colorectal cancer exemplifies the critical role of Minimal Residual Disease (MRD) testing in patient care. Diagnosed in 2018 after severe abdominal pain led to the discovery that 80% of his liver was affected by metastatic disease, Jason faced a daunting prognosis.

Despite initial medical opinions suggesting limited treatment options, Jason pursued aggressive interventions, including liver surgery and chemotherapy. Throughout his treatment, he utilized Signatera™ MRD testing to monitor circulating tumor DNA (ctDNA) levels in his blood, enabling early detection of potential recurrences and informed decision-making regarding his treatment plan.

Each test result provided valuable insights:

  • When results were negative, Jason felt reassured that no cancer DNA (ctDNA) was detected, allowing him to focus on living his life.
  • When ctDNA was detected, it signaled early molecular recurrence before it could be seen on scans, giving his medical team the opportunity to adjust treatment and address the cancer early.

Over time, regular MRD testing gave Jason a sense of control over his care. He could make informed decisions alongside his doctor, ensuring that any recurrence was caught at the earliest possible stage.

Today, Jason channels his experience into supporting others through initiatives like the Kohala House of Healing, a cancer retreat in Hawaii dedicated to offering hope and healing to those affected by cancer. His story is a testament to the power of proactive monitoring and patient-centered care.

Meet Jason and listen to his CRC Survivor Story:

Why Regular MRD Testing Matters for CRC Patients

MRD testing is a game-changer for colorectal cancer patients, particularly those who are:

  • Post-surgery – To detect any remaining cancer cells and determine if additional treatment is needed.
  • In remission – To track molecular recurrence before it becomes visible on scans.
  • Undergoing treatment – To assess how well the treatment is working and adjust accordingly.

Unlike traditional imaging scans, which can only detect larger tumors, MRD testing detects tiny amounts of cancer DNA in the blood—often months before recurrence would appear on a scan. This early warning allows patients and doctors to act sooner, when the disease may be more manageable.

The Emotional and Clinical Benefits of MRD Testing

For many patients, waiting months between scans can be filled with anxiety. MRD testing offers a way to stay informed and proactive:

  • Reduces uncertainty – Knowing whether cancer DNA is present or not helps patients feel more in control.
  • Guides treatment decisions – Helps oncologists determine if further treatment is needed or if current therapies are effective.
  • Provides peace of mind – When results are negative, it reinforces that no molecular recurrence has been detected.

Taking the Next Step: Is MRD Testing Right for You?

If you’re a colorectal cancer survivor, MRD testing can be an essential tool in your ongoing care. Talk to your doctor about whether Signatera™ MRD testing could help you stay ahead of recurrence and make more informed treatment decisions.

Learn more about MRD testing and patient experiences like Jason’s here.